Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Hemodial Int. 2016 Jun 21;20(4):510–521. doi: 10.1111/hdi.12435

Figure 1.

Figure 1

Change in carbamylated albumin by treatment group. Figure shows unadjusted mean baseline and end of study (1 year) carbamylated albumin levels±stand errors in EHD patients (closed circle) and controls (open circle); mean values did not differ significantly between treatment groups at baseline (P=0.26). Values listed in figure are mean 12-month change in carbamylated albumin by treatment group and associated P value.